Reno, Nevada (UroToday.com) Clarity Pharmaceuticals (ASX: CU6) (“Clarity”, “the Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve ...

Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database - Beyond the Abstract ...

The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement. October 3, 2024 Bacillus Calmette-Guerin (BCG) Vaccine Impact on ...

Our recent investigation into the spatial cellular landscape of localized prostate tumors provides a comprehensive analysis of over 20 androgen receptor (AR)-positive immune and non-immune stromal ...

The 2024 American Society for Radiation Oncology (ASTRO) annual meeting held in Washington D.C., between September 29 and ...

Muscle-invasive bladder cancer (MIBC) requires an aggressive treatment strategy that typically involves neoadjuvant chemotherapy (NAC) followed by radical cystectomy with pelvic lymph node dissection.

The 2024 American Society for Radiation Oncology (ASTRO) annual meeting held in Washington D.C., between September 29 and ...

(UroToday.com) The House of Delegates (HOD) convened at the American Medical Association (AMA) Annual Meeting in Chicago, IL, in June 2024. During the HOD, voting members of the legislative body of ...

This systematic review analyzed evidence related to risk factors for Incontinence Associated Dermatitis (IAD) in critically ill incontinent patients. Systematic review and meta-analysis. Eight ...

Localized node-positive bladder cancer is characterized by a high degree of heterogeneity, leading to significant variability in overall survival outcomes among affected individuals. The absence of ...

Patients with resected localized clear-cell renal cell carcinoma (ccRCC) remain at variable risk of recurrence. Incorporation of biomarkers may refine risk prediction and inform adjuvant treatment ...

Renal transplantation and end-stage renal disease are increasingly common. Renal dysfunction and immunosuppression are two risk factors in the development of renal cell carcinoma. Carcinomas in these ...